Abstract
Prostanoid receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Prostanoid Receptors [694]) are activated by the endogenous ligands prostaglandins PGD2, PGE1, PGE2 , PGF2α, PGH2, prostacyclin [PGI2] and thromboxane A2. Differences and similarities between human and rodent prostanoid receptor orthologues, and their specific roles in pathophysiologic conditions are reviewed in [448]. Measurement of the potency of PGI2 and thromboxane A2 is hampered by their instability in physiological salt solution; they are often replaced by cicaprost and U46619, respectively, in receptor characterization studies.
| Original language | English |
|---|---|
| Journal | IUPHAR/BPS Guide to Pharmacology CITE |
| Volume | 2021 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 25 Jun 2021 |
Fingerprint
Dive into the research topics of 'Prostanoid receptors in GtoPdb v.2021.2'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver